Urticaria Global Market Report 2025

Description

Urticaria, commonly known as hives, is a skin condition characterized by red, itchy, and raised welts. It results from an allergic reaction, stress, or unknown triggers, leading to the release of histamine. The condition can be acute (lasting less than six weeks) or chronic (persisting for longer periods). Treatment typically includes antihistamines, avoiding triggers, and, in more severe cases, corticosteroids or immunotherapy.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of urticaria are acute urticaria and chronic urticaria. Acute urticaria is a sudden-onset condition that lasts less than six weeks, marked by red, itchy, and swollen welts, often triggered by allergic reactions, infections, medications, insect stings, or food allergens. Treatment options include drug classes such as antihistamines, anti-inflammatory medications, antidepressants, monoclonal antibodies, and others, administered through oral, parenteral, or other routes. These treatments are distributed via various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, serving end users such as hospitals, homecare settings, specialty clinics, and others.

The Urticaria market research report is one of a series of new reports from The Business Research Company that provides Urticaria market statistics, including Urticaria industry global market size, regional shares, competitors with a Urticaria market share, detailed Urticaria market segments, market trends and opportunities, and any further data you may need to thrive in the Urticaria industry. This Urticaria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urticaria market size has grown rapidly in recent years. It will grow from$4.03 billion in 2024 to $4.77 billion in 2025 at a compound annual growth rate (CAGR) of 18.2%. The growth during the historic period can be attributed to factors such as the increasing prevalence of allergies, growing awareness of skin disorders, advancements in immunology and biologics, rising demand for antihistamines, and improvements in diagnostic techniques.

The urticaria market size is expected to see rapid growth in the next few years. It will grow to$9.23 billion in 2029 at a compound annual growth rate (CAGR) of 18.0%. The growth during the forecast period can be attributed to factors such as the rising cases of chronic urticaria, growing adoption of biologic therapies, increasing investments in dermatology research, expanding access to advanced allergy diagnostics, and the development of personalized medicine. Key trends during this period include AI-powered diagnostic tools, the development of novel biologics, advancements in personalized immunotherapy, wearable skin monitoring devices, and the use of telemedicine for allergy management.

The growing awareness and treatment of skin diseases are expected to drive the growth of the urticaria market in the coming years. Rising pollution levels contribute to an increase in skin allergies and conditions, boosting the demand for better awareness and advanced treatments. Urticaria plays a significant role in increasing skin disease awareness and treatment by highlighting immune system responses, promoting research, improving diagnostics, and advancing targeted therapies. For example, in February 2024, The Skin Cancer Foundation, a US-based nonprofit, reported that 1 in 5 Americans will develop skin cancer by age 70, with over 2 deaths occurring every hour in the U.S. This underscores the urgent need for preventive measures, as having five or more sunburns doubles the risk of melanoma. As such, the rising awareness and treatment of skin diseases are propelling the growth of the urticaria market.

Key players in the market are focusing on innovative solutions such as mast cell inhibitor antibodies to manage chronic spontaneous urticaria by targeting mast cell activation. Mast cell inhibitor antibodies are monoclonal antibodies that block the activation or degranulation of mast cells by inhibiting specific receptors or signaling pathways, thereby reducing allergic reactions, inflammation, and other mast cell-mediated disorders. For instance, in May 2024, Allakos Inc., a US-based biotechnology company, announced the initiation of a Phase 1 clinical trial for AK006, a treatment for chronic spontaneous urticaria (CSU). This innovative therapy targets both IgE-dependent and IgE-independent mast cell activation pathways, offering the potential for greater efficacy in patients who are resistant to antihistamines or prior biologic treatments. By selectively inhibiting mast cell activity through the Siglec-6 receptor, AK006 aims to provide a more comprehensive and lasting solution for CSU management, marking a significant step forward in urticaria treatment and immunotherapy research.

In April 2024, Incyte Corporation, a US-based biopharmaceutical company, acquired Escient Pharmaceuticals for $750 million. This acquisition aims to enhance Incyte's portfolio in inflammation and autoimmunity by advancing first-in-class oral Mas-related G protein-coupled receptor X2 (MRGPRX2) and Mas-related G protein-coupled receptor X4 (MRGPRX4) antagonists, which have the potential to improve treatments for chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), atopic dermatitis (AD), cholestatic pruritus, and other inflammatory disorders. Escient Pharmaceuticals, a US-based clinical-stage biotechnology company, focuses on developing small-molecule therapies for chronic urticaria and severe pruritus.

Major players in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd., Dr. Reddy's Laboratories Ltd, Cipla Ltd., Amneal Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Almirall S.A., Argenx SE, BioCryst Pharmaceuticals Inc., Pharvaris NV, Revolution Medicines Inc., and Allakos.

North America was the largest region in the urticaria market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urticaria report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the urticaria market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The urticaria market consists of sales of corticosteroids, biologics, immunosuppressants, leukotriene receptor antagonists, and topical anti-inflammatory creams or gels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Urticaria Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on urticaria market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for urticaria ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The urticaria market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Acute Urticaria; Chronic Urticaria
2) By Drug Class: Antihistamines; Anti-inflammation Medications; Antidepressants; Monoclonal Antibodies; Other Drug Classes
3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Acute Urticaria: Allergic Urticaria; Infectious Urticaria; Drug-Induced Urticaria; Contact Urticaria
2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU); Chronic Inducible Urticaria (CIndU)
Companies Mentioned: Sanofi S.A.; Novartis AG; GlaxoSmithKline PLC; Roche Holding AG; Viatris Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35006

1. Executive Summary

2. Urticaria Market Characteristics

3. Urticaria Market Trends And Strategies

4. Urticaria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Urticaria Growth Analysis And Strategic Analysis Framework

5.1. Global Urticaria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Urticaria Market Growth Rate Analysis
5.4. Global Urticaria Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Urticaria Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Urticaria Total Addressable Market (TAM)

6. Urticaria Market Segmentation

6.1. Global Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Urticaria
Chronic Urticaria
6.2. Global Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Anti-Inflammation Medications
Antidepressants
Monoclonal Antibodies
Other Drug Classes
6.3. Global Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.4. Global Urticaria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users
6.6. Global Urticaria Market, Sub-Segmentation Of Acute Urticaria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergic Urticaria
Infectious Urticaria
Drug-Induced Urticaria
Contact Urticaria
6.7. Global Urticaria Market, Sub-Segmentation Of Chronic Urticaria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chronic Spontaneous Urticaria (CSU)
Chronic Inducible Urticaria (CIndU)

7. Urticaria Market Regional And Country Analysis

7.1. Global Urticaria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Urticaria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Urticaria Market

8.1. Asia-Pacific Urticaria Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Urticaria Market

9.1. China Urticaria Market Overview
9.2. China Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Urticaria Market

10.1. India Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Urticaria Market

11.1. Japan Urticaria Market Overview
11.2. Japan Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Urticaria Market

12.1. Australia Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Urticaria Market

13.1. Indonesia Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Urticaria Market

14.1. South Korea Urticaria Market Overview
14.2. South Korea Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Urticaria Market

15.1. Western Europe Urticaria Market Overview
15.2. Western Europe Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Urticaria Market

16.1. UK Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Urticaria Market

17.1. Germany Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Urticaria Market

18.1. France Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Urticaria Market

19.1. Italy Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Urticaria Market

20.1. Spain Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Urticaria Market

21.1. Eastern Europe Urticaria Market Overview
21.2. Eastern Europe Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Urticaria Market

22.1. Russia Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Urticaria Market

23.1. North America Urticaria Market Overview
23.2. North America Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Urticaria Market

24.1. USA Urticaria Market Overview
24.2. USA Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Urticaria Market

25.1. Canada Urticaria Market Overview
25.2. Canada Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Urticaria Market

26.1. South America Urticaria Market Overview
26.2. South America Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Urticaria Market

27.1. Brazil Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Urticaria Market

28.1. Middle East Urticaria Market Overview
28.2. Middle East Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Urticaria Market

29.1. Africa Urticaria Market Overview
29.2. Africa Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Urticaria Market Competitive Landscape And Company Profiles

30.1. Urticaria Market Competitive Landscape
30.2. Urticaria Market Company Profiles
- 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Urticaria Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd
31.2. Sun Pharmaceutical Industries Ltd
31.3. Incyte Corporation
31.4. Kyowa Kirin Co. Ltd.
31.5. Dr. Reddy's Laboratories Ltd
31.6. Cipla Ltd.
31.7. Amneal Pharmaceuticals Inc
31.8. Glenmark Pharmaceuticals Ltd
31.9. Torrent Pharmaceuticals
31.10. Almirall S.A.
31.11. Argenx SE
31.12. BioCryst Pharmaceuticals Inc.
31.13. Pharvaris NV
31.14. Revolution Medicines Inc.
31.15. Allakos

32. Global Urticaria Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Urticaria Market

34. Recent Developments In The Urticaria Market

35. Urticaria Market High Potential Countries, Segments and Strategies

35.1 Urticaria Market In 2029 - Countries Offering Most New Opportunities
35.2 Urticaria Market In 2029 - Segments Offering Most New Opportunities
35.3 Urticaria Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r35006_Urticaria_GMR_2025